Patrizia Ronchetto
Istituto Giannina Gaslini
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Patrizia Ronchetto.
Orphanet Journal of Rare Diseases | 2011
Cristina Cuoco; Patrizia Ronchetto; Stefania Gimelli; Frédérique Béna; Maria Teresa Divizia; Margherita Lerone; Marisol Mirabelli-Badenier; Monica Mascaretti; Giorgio Gimelli
Backgroundterminal deletions of the distal portion of the short arm of chromosome 3 cause a rare contiguous gene disorder characterized by growth retardation, developmental delay, mental retardation, dysmorphisms, microcephaly and ptosis. The phenotype of individuals with deletions varies from normal to severe. It was suggested that a 1,5 Mb minimal terminal deletion including the two genes CRBN and CNTN4 is sufficient to cause the syndrome.In addition the CHL1 gene, mapping at 3p26.3 distally to CRBN and CNTN4, was proposed as candidate gene for a non specific mental retardation because of its high level of expression in the brain.Methods and Resultswe describe two affected siblings in which array-CGH analysis disclosed an identical discontinuous terminal 3p26.3 deletion spanning less than 1 Mb. The deletion was transmitted from their normal father and included only the CHL1 gene. The two brothers present microcephaly, light mental retardation, learning and language difficulties but not the typical phenotype manifestations described in 3p- syndrome.Conclusiona terminal 3p26.3 deletion including only the CHL1 gene is a very rare finding previously reported only in one family. The phenotype of the affected individuals in the two families is very similar and the deletion has been inherited from an apparently normal parent. As already described for others recurrent syndromes with variable phenotype, these findings are challenging in genetic counselling because of an evident variable penetrance.
Clinical Genetics | 2008
Carmelina Magnani; Laura Cremonesi; Elena Belloni; Maurizio Ferrari; Manuela Seia; Maria Pia Russo; Marcella Devoto; Patrizia Ronchetto; Giovanni Romeo
Molecular diagnosis of cystic fibrosis (CF) in the Italian population, based on the detection of the deltaF508 mutation (51.2% of CF chromosomes), provides full informativity for prenatal diagnosis (PDN) in about 28% of families at risk. Identification of the predominant non‐deltaF508 mutations allows the characterization of about 70% of CF chromosomes, making approximately 48% of couples fully informative. In families where at least one chromosome remains uncharacterized, allele segregation is still determined using RFLPs closely linked to the CF gene. The recent identification of three polymorphic clusters of dinucleotide repeats (IVS8/ GT, IVS17b/TA and IVS17b/CA) led us to evaluate whether their analysis might improve feasibility studies for prenatal diagnosis or hetero‐zygote identification. One hundred nuclear families with a CF child, reflecting the general Italian deltaF508 mutation distribution, were geno‐typed for the three microsatellites. In this study microsatellite analysis using IVS8/GT and IVS17b/TA allowed the identification of both parental CF chromosomes in 94% of couples; inclusion in the study of the less polymorphic repeat locus, IVS17b/CA, slightly improved this percentage (97%). Hence, a strategy involving primarily the detection of the delta F508 mutation and secondarily microsatellite analysis makes possible PDN of CF in virtually all Italian CF families.
Clinical Genetics | 2008
Graziella Borgo; G. Cabrini; Gianni Mastella; Patrizia Ronchetto; Marcella Devoto; Giovanni Romeo
Clin Genet 1993: 44: 48–49.
Cytogenetic and Genome Research | 2015
Elisa Tassano; Alessandra Gamucci; Maria Elena Celle; Patrizia Ronchetto; Cristina Cuoco; Giorgio Gimelli
Interstitial 1p deletions are rare events. Very few cases of 1p31.1p31.3 deletions characterized by variable phenotypes have been reported. No clear genotype-phenotype correlation has been determined yet. We present a child with a de novo interstitial 1p31.1p31.3 deletion, identified by array CGH, associated with intellectual disability and severe language impairment. The deleted region contains 20 OMIM genes, but we focused on GADD45A (MIM 126335; growth arrest- and DNA damage-inducible gene), LRRC7 (MIM 614453; leucine-rich repeat-containing protein 7), and NEGR1 (MIM 613173; neuronal growth regulator 1). We discuss whether these genes play a role in determining the phenotype of our patient in order to investigate the possibility of a genotype-phenotype correlation.
Journal of Applied Genetics | 2013
S. Gimelli; Cristina Cuoco; Patrizia Ronchetto; Giorgio Gimelli; Elisa Tassano
Hemifacial microsomia (HFM) is defined as a condition affecting primarily aural, oral, and mandibular development. The disorder varies from mild to severe, and occurs on one side in many cases, is rarely bilateral, with more severe expression on one side. Goldenhar syndrome is considered to be a variant of this complex, characterized by vertebral anomalies and epibulbar dermoids. Actually, the term oculoauriculo-vertebral spectrum (OAVS) is employed to group these syndromes, which are extremely complex and heterogeneous (Gorlin 2001). The principal features include facial asymmetry, secondary to maxillary and mandibular hypoplasia, underdevelopment of the external ear (microtia) often associated with preauricular skin tags or pits, and conductive hearing loss (Kelberman et al. 2001). There may be ocular dermoids and these cases tend to be given the diagnosis of Goldenhar syndrome (Tasse et al. 2005). Skeletal alterations mainly consist of vertebral anomalies. Other craniofacial features, including macrostomia, micrognathia, and cleft lip with or without cleft palate, can be present. Cardiac, renal, skeletal, and central nervous system defects are more rarely observed. Most cases are sporadic, but there are rare familial cases that exhibit an autosomal dominant inheritance. Expression varies within families. Several chromosomal abnormalities have been associated with OAVS syndrome, but no recurrent chromosomal abnormalities were identified, also in a recent study, by array comparative genomic hybridization (CGH), on a cohort of 86 patients (Rooryck et al. 2010). Genetic linkage studies identified a candidate region in 14q32 containing the GSC (goosecoid) gene (Kelberman et al. 2001). The authors considered GSC as a positional candidate gene for OAVS, but did not find any mutation within the coding region. Therefore, OAVS can be defined as a phenotypically and genetically heterogeneous disorder, and different pathogenic causes may concur to the disease. Here, we report on a 14q31.1q31.3 interstitial deletion transmitted from a mother to her daughter, both presenting features of HFM.
Human Genetics | 1990
Laura Cremonesi; Luca Ruocco; Manuela Seia; Silvia Russo; Annamaria Giunta; Patrizia Ronchetto; Laura Fenu; Luca Romano; Marcella Devoto; Giovanni Romeo; Maurizio Ferrari
SummaryA sample of 175 Italian cystic fibrosis patients has been analysed for the presence of the ΔF508 mutation. The frequency of this mutation among 137 patients with pancreatic insufficiency is equal to 57%; in 23 patients with pancreatic sufficiency it is 26%. A high proportion of the unknown mutations is associated with the same rare haplotype found in association with ΔF508, suggesting that at least another mutation occurred on a chromosome characterized by the same haplotype.
Advances in Experimental Medicine and Biology | 1991
Patrizia Ronchetto; Laura Fenu; Aldamaria Puliti; Marcella Devoto; Luca Romano; Giovanni Romeo; Laura Cremonesi; Paola Carrera; Luca Ruocco; Manuela Seia; Silvia Russo; Annamaria Giunta; Maurizio Ferrari
The gene responsible for cystic fibrosis (CF) has been recently cloned (Rommens et al., 1989; Riordan et al., 1989; Kerem et al., 1989) and the most common mutation causing CF (deltaF508) has been identified as a three base pair deletion at codon 508 of exon 10 removing a phenylalanine. Since then other mutations have been identified in different exons, and the information necessary for their detection has been distributed through the CF Genetic Analysis Consortium (L.-C. Tsui, personal communications).
European Journal of Medical Genetics | 2018
Giulia Rosti; Elisa Tassano; Simone Bossi; Maria Teresa Divizia; Patrizia Ronchetto; Martina Servetti; Margherita Lerone; Livia Pisciotta; Maria Margherita Mancardi; Edvige Veneselli; Aldamaria Puliti
The KCNQ5 gene, widely expressed in the brain, encodes a voltage-gated potassium channel (Kv7.5) important for neuronal function. Here, we report a novel KCNQ5 intragenic duplication at 6q13 spanning about 239 Kb of genomic DNA, identified by array comparative genomic hybridization (array-CGH). The duplication was found in heterozygosity in an adult patient affected by mild intellectual disability with history of absence epilepsy in adolescence, with no EEG nor MRI alterations. By in vitro analyses we demonstrated that this copy number variation (CNV) led to an aberrant transcript with exon 2-11 skipping and a premature stop codon causing, most likely, haploinsufficiency. The Kv7.5 channel plays an important role in the regulation of M-type current and afterhyperpolarization conductances which contribute to neuronal excitability. A recently published paper described KCNQ5 missense mutations in individuals with intellectual disability and treatment-resistant epilepsy that were thought to act through either loss-of-function or gain-of-function mechanisms, associated in both cases with altered neuronal excitability. In the case reported here, we showed that no functional protein can be produced from the allele involved by the intragenic duplication. This evidence strongly supports the hypothesis of KCNQ5 haploinsufficiency, which could lead to altered neuronal excitability, thus contributing to seizure susceptibility and intellectual disability.
European Journal of Medical Genetics | 2018
Elisa Tassano; Sara Uccella; Thea Giacomini; Mariasavina Severino; Laura Siri; Marcella Gherzi; Maria Elena Celle; Simona Porta; Giorgio Gimelli; Patrizia Ronchetto
Heterogeneous clinical and neuropsychological features, such as intellectual disability, developmental and language delay, hypotonia, and, to a lesser extent, microcephaly that is present in about the half of the reported patients, characterize the 3q29 microduplication syndrome with usually a milder phenotype compared with the corresponding 3q29 microdeletion syndrome. The duplications described so far range from 2.3 Mb to 1.6 Mb, spanning from TFRC to BDH1 genes. Here we report on two patients with overlapping interstitial duplications of the 3q29 region differing in size. Patient 1 harboured a common-seized 3q29 microduplication spanning ∼1.6 Mb, while patient 2 carried a very small 3q29 microduplication of 448.8 Kb encompassing only two genes, DLG1 and BDH1. Both patients presented clinical characteristics similar to those reported in the literature in 3q29 microduplication syndrome. Interestingly, heterotopic gray matter nodules were found along the right lateral ventricle on brain MRI in patient 1, thus expanding the neuroradiological phenotype in 3q29 microduplication syndrome, while patient 2 allowed us to define with more precision the smallest region of overlap (SRO). Gene content analysis of the duplicated region suggests that gain-of-dosage of DLG1 and BDH1 may be a good candidate for the main clinical features of this syndrome.
Cytogenetic and Genome Research | 2018
Elisa Tassano; Sara Uccella; Thea Giacomini; Pasquale Striano; Mariasavina Severino; Simona Porta; Giorgio Gimelli; Patrizia Ronchetto
ULK4 and BRWD3 deletions have been identified in patients with developmental/language delay and intellectual disability. Both genes play pivotal roles in brain development. In particular, ULK4 encodes serine/threonine kinases that are critical for the development and function of the nervous system, while BRWD3 plays a crucial role in ubiquitination, as part of the ubiquitin/proteasome system. We report on 2 brothers, aged 7.6 and 20 years, presenting with cognitive impairment, epilepsy, autistic features, hearing loss, and obesity. Array-CGH analysis demonstrated 2 rare CNVs in both siblings: a paternally inherited microdeletion of ∼145 kb at 3p22.1, disrupting the ULK4 gene, and a maternally inherited microduplication of ∼117 kb at Xq21.1 including only the BRWD3 gene. As already described for other recurrent syndromes with variable phenotype, these findings are challenging in genetic counseling because of an evident variable penetrance. We discuss the possible correlations between the clinical phenotype of our patients and the function of the genes involved in these microrearrangements.